India Pacemaker Market is flourishing due to the rising prevalence of cardiovascular diseases, growing geriatric population, increasing life expectancy, and government’s supportive reimbursement ...

The guidelines recommend that in patients carrying either a pacemaker or an ICD the device ... to the manufacturer of the magnet). Boston Scientific CRM recommends using a programmer to ...

Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer ...

About Boston Scientific Corporation and Thermo Fisher Scientific Inc ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, ...

Boston Scientific Corporation develops ... cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor ...

New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...

Shares of Boston Scientific Corp. BSX slumped 0.15% to $84.41 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to ...

The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...

Boston Scientific Corp. closed $0.35 short of its 52-week high ($84.89), which the company achieved on September 19th.

The Accent MRI pacemaker, with the Tendril MRI lead, is an MRI conditional system, offering safe performance of a full-body MRI scan on the patient using a 1.5 T (Tesla) field-strength MRI scanner.

Boston Scientific Corporation BSX is gaining traction in the international regions. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks ...